Education
About Us
Working with TipRanks
Follow Us
PharmaSGP Holding SE (DE:PSG)
:PSG
Total Valuation
PharmaSGP Holding SE has a market cap or net worth of €321.60M. The enterprise value is ―.
Market Cap€321.60M
Enterprise Value―
Share Statistics
PharmaSGP Holding SE has 12,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PharmaSGP Holding SE’s return on equity (ROE) is 0.41 and return on invested capital (ROIC) is 16.07%.
Return on Equity (ROE)0.41
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)16.07%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee1.11M
Profits Per Employee180.19K
Employee Count91
Asset Turnover0.77
Inventory Turnover0.94
Valuation Ratios
The current PE Ratio of PharmaSGP Holding SE is 16.46. PharmaSGP Holding SE’s PEG ratio is -0.58.
PE Ratio16.46
PS Ratio0.00
PB Ratio7.79
Price to Fair Value6.79
Price to FCF10.87
Price to Operating Cash Flow10.27
PEG Ratio-0.58
Income Statement
In the last 12 months, PharmaSGP Holding SE had revenue of 101.10M and earned 16.40M in profits. Earnings per share was 1.37.
Revenue101.10M
Gross Profit91.64M
Operating Income24.64M
Pretax Income21.89M
Net Income16.40M
EBITDA35.87M
Earnings Per Share (EPS)1.37
Cash Flow
In the last 12 months, operating cash flow was 28.02M and capital expenditures -1.55M, giving a free cash flow of 26.47M billion.
Operating Cash Flow28.02M
Free Cash Flow26.47M
Free Cash Flow per Share2.21
Dividends & Yields
PharmaSGP Holding SE pays an annual dividend of €1.36, resulting in a dividend yield of 5.07%
Dividend Per Share€1.36
Dividend Yield5.07%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.10
52-Week Price Change24.94%
50-Day Moving Average24.80
200-Day Moving Average24.02
Relative Strength Index (RSI)69.55
Average Volume (3m)890.00
Important Dates
PharmaSGP Holding SE upcoming earnings date is May 28, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateMay 28, 2025
Ex-Dividend DateJun 26, 2025
Financial Position
PharmaSGP Holding SE as a current ratio of 2.55, with Debt / Equity ratio of 1.65%
Current Ratio2.55
Quick Ratio2.14
Debt to Market Cap0.27
Net Debt to EBITDA0.93
Interest Coverage Ratio5.59
Taxes
In the past 12 months, PharmaSGP Holding SE has paid 5.50M in taxes.
Income Tax5.50M
Effective Tax Rate0.25
Enterprise Valuation
PharmaSGP Holding SE EV to EBITDA ratio is 8.45, with an EV/FCF ratio of 11.76.
EV to Sales3.00
EV to EBITDA8.45
EV to Free Cash Flow11.76
EV to Operating Cash Flow11.38
Balance Sheet
PharmaSGP Holding SE has €37.77M in cash and marketable securities with €608.00K in debt, giving a net cash position of -€37.16M billion.
Cash & Marketable Securities€37.77M
Total Debt€608.00K
Net Cash-€37.16M
Net Cash Per Share-€3.10
Tangible Book Value Per Share-€2.19
Margins
Gross margin is 83.26%, with operating margin of 24.37%, and net profit margin of 16.22%.
Gross Margin83.26%
Operating Margin24.37%
Pretax Margin21.66%
Net Profit Margin16.22%
EBITDA Margin35.48%
EBIT Margin26.28%
Analyst Forecast
The average price target for PharmaSGP Holding SE is €37.63, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€37.63
Price Target Upside40.41% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―